Bilenker Joshua H. 4
4 · Sana Biotechnology, Inc. · Filed Jun 9, 2025
Insider Transaction Report
Form 4
Bilenker Joshua H.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-05+80,000→ 80,000 totalExercise: $2.55Exp: 2035-06-04→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date.